Synapse - Hematologic Malignancies Service

Search Within

Hematologic Malignancies Service

Results (614)

Phase II study of responses to vaccination in pediatric cancer survivors following standard-of-care non-HSCT chemotherapy

Journal Article

Junak, S.; Steinherz, P. G.; Trippett, T.; Ruggiero, J.; Zakak, N.; Khakoo, Y.; Shukla, N.; Dunkel, I. J.; Kernan, N. A.
Pediatric Blood and Cancer (2025)

Fulltext@MSK | Save

Treatment of T-cell leukemia/lymphoma in children and young adults with the Memorial Sloan Kettering Cancer Center New York IIB protocol

Journal Article

Steinherz, P. G.; Mauguen, A.; Suser, S.; Ramaswamy, K.; Kobos, R.; Forlenza, C. J.; Shukla, N.; Trippett, T.; Wolden, S.; Steinherz, L.
Journal of Pediatric Hematology/Oncology (2025)

Fulltext@MSK | Save

3D chromatin hubs as regulatory units of identity and survival in human acute leukemia

Journal Article

Gambi, G.; Boccalatte, F.; Rodriguez Hernaez, J.; Lin, Z.; Nadorp, B.; Polyzos, A.; Tan, J.; Avrampou, K.; Inghirami, G.; Kentsis, A.; more...
Molecular Cell (2025)

Fulltext@MSK | Save

A multi-site break through cancer trial: Phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress)

Meeting Abstract

Issa, G. C.; Ambinder, A. J.; Xiao, W.; Manalis, S.; Shalek, A. K.; Gondek, L. P.; Kentsis, A.; Short, N. J.; Daver, N.; Ning, J.; more...
Blood (2024)

Fulltext@MSK | Save

A phase II study of the menin inhibitor revumenib in leukemia associated with upregulation of HOX genes: Trial in progress

Meeting Abstract

Issa, G. C.; Chin, K. K.; Blachly, J. S.; Farhat, A.; Xiao, L.; Ning, J.; Cuglievan, B.; Shukla, N.; Sasaki, K.; Loghavi, S.; more...
Blood (2024)

Fulltext@MSK | Save

Safety and efficacy in pediatric patients with relapsed/refractory classic Hodgkin lymphoma enrolled on an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin (E4412)

Meeting Abstract

Forlenza, C. J.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Cole, P. D.; Kahl, B. S.; more...
Blood (2024)

Fulltext@MSK | Save

Retrospective cohort analysis of response and survival of children, adolescents, and young adults (CAYA) with relapsed and/or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) and lymphoma (T-LL) treated with curative intent: A TACL consortium study

Meeting Abstract

Pauly, M. G.; Chi, Y. Y.; Malvar, J.; Leong, R.; Colace, S.; Gossai, N.; Hijiya, N.; Parekh, C.; Rheingold, S. R.; Verma, A.; more...
Blood (2024)

Fulltext@MSK | Save

Pembrolizumab in children, adolescents, and young adults with low-risk classic Hodgkin lymphoma (cHL) and slow early response to front-line chemotherapy: Updated results from the phase 2 KEYNOTE-667 study

Meeting Abstract

Roth, L. G.; Toledo, M. M.; Keller, F. G.; Hoppe, B.; Forlenza, C. J.; Castellino, S. M.; Catalan, M. A.; Krystal, J.; Lamble, A.; Luisi, F.; more...
Blood (2024)

Fulltext@MSK | Save

Updated results and longer follow-up from the AUGMENT-101 phase 2 study of revumenib in all patients with relapsed or refractory (R/R) KMT2Ar acute leukemia

Meeting Abstract

Aldoss, I.; Issa, G. C.; Blachly, J. S.; Thirman, M. J.; Mannis, G. N.; Arellano, M. L.; DiPersio, J. F.; Traer, E.; Zwaan, C. M.; Shukla, N.; more...
Blood (2024)

Fulltext@MSK | Save

Proteolytic control and therapeutic targeting of oncogenic gene expression in acute myeloid leukemia

Meeting Abstract

Uni, M.; Steinberg, A. P.; Slavit, A.; Rha, S.; Cheng, S.; Schmalbrock, L. K.; Su, J.; Ma, J.; McPherson, A.; Mullighan, C. G.; more...
Blood (2024)

Fulltext@MSK | Save